Dalde, Khasimira A.
HRN: 16-62-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
CEFUROXIME 750MG (VIAL)
10/07/2023
10/14/2023
IV
750mg
Q8hours
PCAP-C; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes